Glibenclamide(CAS 10238-21-8)Type 2 diabetes treatment API

Glibenclamide (widely known as Glyburide in the United States) is an oral antidiabetic medication classified as a sulfonylurea. It is primarily prescribed to help manage and lower blood glucose levels in adults with type 2 diabetes mellitus, specifically for patients whose blood sugar cannot be adequately controlled by diet and exercise alone.The medication works efficiently by stimulating the beta cells in the pancreas to produce and release more insulin, the essential hormone responsible for processing sugar in the bloodstream. Additionally, it helps enhance tissue sensitivity to insulin, allowing the body to utilize the hormone more effectively.